insights

Clinical Trial Agreements in the Age of AI: Our Series Featured in Clinical Leader

06-24-26 Alert Katherine Leibowitz

Clinical Leader recently featured Leibowitz Law’s insights on how AI is reshaping clinical trial operations and what that means for clinical trial agreements.

Read the articles:

Part 1: Where AI Appears In Clinical Trials — And Why Contracts Need To Catch Up
Part 2: Contracting For AI In Clinical Trials: Data Rights And Regulatory Compliance
Part 3: Contracting For AI In Clinical Trials: Cybersecurity, Monitoring, And Risk Allocation

Many thanks to Clinical Leader for featuring this series.

If you have any questions or would like more information about these developing issues, please contact the following:

KATHERINE LEIBOWITZ
1-610-896-5788
Katherine.Leibowitz@LeibowitzLawTeam.com

SHARE: LINKEDIN TWITTER

This contents of this alert should not be construed as legal advice or a legal opinion on any specific facts or circumstances. This content is not intended to and does not, by its receipt, create an attorney-client relationship. The contents are intended for general informational purposes only. We urge you to consult your attorney about the specific situation and any legal questions you may have. Attorney advertising in some jurisdictions. © 2025 Leibowitz Law. All rights reserved. “Leibowitz Law” is a trade name of Leibowitz LLC.

Want to receive notifications?

To be notified when we post new Insights, please sign up for our email list. As industry thought leaders, Leibowitz Law Insights address developing issues at the intersection of law, regulation, technology and life sciences…